Rezultaty - Noriyuki Namba
- Rezultaty 1 - 17 Rezultaty od 17
-
1
-
2
-
3
<i>Lrp6</i> Hypomorphic Mutation Affects Bone Mass Through Bone Resorption in Mice and Impairs Interaction With Mesd od Takuo Kubota, Toshimi Michigami, Naoko Sakaguchi, Chikara Kokubu, Akira Suzuki, Noriyuki Namba, Norio Sakai, Shigeo Nakajima, Kenji Imai, Keiichi Ozono
Wydane 2008Artigo -
4
Overgrowth syndrome associated with a gain‐of‐function mutation of the natriuretic peptide receptor 2 (<i>NPR2</i>) gene od Kohji Miura, Ok‐Hwa Kim, Hey Ran Lee, Noriyuki Namba, Toshimi Michigami, Won Joon Yoo, In Ho Choi, Keiichi Ozono, Tae‐Joon Cho
Wydane 2013Artigo -
5
Clinical Practice Guidelines for Hypophosphatasia* od Toshimi Michigami, Yasuhisa Ohata, Makoto Fujiwara, Hiroshi Mochizuki, Masanori Adachi, Taichi Kitaoka, Takuo Kubota, Hideaki Sawai, Noriyuki Namba, Kosei Hasegawa, Ikuma Fujiwara, Keiichi Ozono
Wydane 2020Artigo -
6
Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment od Itsuro Endo, Seiji Fukumoto, Keiichi Ozono, Noriyuki Namba, Daisuke Inoue, Ryo Okazaki, Mika Yamauchi, Toshitsugu Sugimoto, Masanori Minagawa, Toshimi Michigami, Masaki Nagai, Toshio Matsumoto
Wydane 2015Artigo -
7
Circulating Levels of Soluble α-Klotho Are Markedly Elevated in Human Umbilical Cord Blood od Yasuhisa Ohata, Hitomi Arahori, Noriyuki Namba, Taichi Kitaoka, Haruhiko Hirai, Kazuko Wada, Masahiro Nakayama, Toshimi Michigami, Akihiro Imura, Yo‐ichi Nabeshima, Y. Yamazaki, Keiichi Ozono
Wydane 2011Artigo -
8
Final adult height in long-term growth hormone-treated achondroplasia patients od Daisuke Harada, Noriyuki Namba, Yuki Hanioka, Kaoru Ueyama, Natsuko Sakamoto, Yukako Nakano, Masafumi Izui, Yuiko Nagamatsu, Hiroko Kashiwagi, Miho Yamamuro, Yoshihito Ishiura, Ayako Ogitani, Yoshiki Seino
Wydane 2017Artigo -
9
-
10
An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene od Kohji Miura, Noriyuki Namba, Makoto Fujiwara, Yasuhisa Ohata, Hidekazu Ishida, Taichi Kitaoka, Takuo Kubota, Haruhiko Hirai, Chikahisa Higuchi, Noriyuki Tsumaki, Hideki Yoshikawa, Norio Sakai, Toshimi Michigami, Keiichi Ozono
Wydane 2012Artigo -
11
Elevated Fibroblast Growth Factor 23 Exerts Its Effects on Placenta and Regulates Vitamin D Metabolism in Pregnancy of <i>Hyp</i> Mice od Yasuhisa Ohata, Miwa Yamazaki, Masanobu Kawai, Naoko Tsugawa, Kanako Tachikawa, Tomoko Koinuma, Kazuaki Miyagawa, Akihito Kimoto, Masahiro Nakayama, Noriyuki Namba, Hironori Yamamoto, Toshio Okano, Keiichi Ozono, Toshimi Michigami
Wydane 2014Artigo -
12
<scp>Asia‐Pacific</scp> Consensus Recommendations on <scp>X‐Linked</scp> Hypophosphatemia: Diagnosis, Multidisciplinary Management, and Transition from Pediatric to Adult Care od Craig Munns, Han‐Wook Yoo, Muhammad Yazid Jalaludin, Rashida Farhad Vasanwala, Manju Chandran, Yumie Rhee, Wai Man Betty But, Alice P.S. Kong, Pen‐Hua Su, Nawaporn Numbenjapon, Noriyuki Namba, Yasuo Imanishi, Roderick Clifton‐Bligh, Xiaoping Luo, Weibo Xia
Wydane 2023Revisão -
13
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia od Leanne M. Ward, Francis H. Glorieux, Michael P. Whyte, Craig Munns, Anthony A. Portale, Wolfgang Högler, Jill H. Simmons, Gary S. Gottesman, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Ola Nilsson, Meng Mao, Angel Chen, Alison Skrinar, Mary Scott Roberts, Erik A. Imel
Wydane 2022Artigo -
14
Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects od Y. Yamazaki, Akihiro Imura, Itaru Urakawa, Takashi Shimada, Junko Murakami, Yukiko Aono, Hisashi Hasegawa, Takeyoshi Yamashita, Kimihiko Nakatani, Yoshihiko Saito, Nozomi Okamoto, Norio Kurumatani, Noriyuki Namba, Taichi Kitaoka, Keiichi Ozono, Tomoyuki Sakai, Hiroshi Hataya, Shoji Ichikawa, Erik A. Imel, Michael J. Econs, Y Nabeshima
Wydane 2010Artigo -
15
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period od Leanne M. Ward, Wolfgang Högler, Francis H. Glorieux, Anthony A. Portale, Michael P. Whyte, Craig Munns, Ola Nilsson, Jill H. Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Etienne Sochett, Koji Muroya, Hiroyuki Tanaka, Pisit Pitukcheewanont, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Angel Chen, John L. Merritt, Erik A. Imel
Wydane 2024Artigo -
16
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial od Erik A. Imel, Francis H. Glorieux, Michael P. Whyte, Craig Munns, Leanne M. Ward, Ola Nilsson, Jill H. Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Meng Mao, Chao-Yin Chen, Alison Skrinar, Javier San Martín, Anthony A. Portale
Wydane 2019Artigo -
17
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia od Raja Padidela, Michael P. Whyte, Francis H. Glorieux, Craig Munns, Leanne M. Ward, Ola Nilsson, Anthony A. Portale, Jill H. Simmons, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Angela Williams, Annabel Nixon, Wei Sun, Angel Chen, Alison Skrinar, Erik A. Imel
Wydane 2021Artigo
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Internal medicine
Endocrinology
Biology
Chemistry
Pediatrics
Receptor
Hypophosphatemia
Vitamin D and neurology
Calcium
Biochemistry
Fibroblast growth factor 23
Gene
Genetics
Parathyroid hormone
Rickets
Activator (genetics)
Bone resorption
Context (archaeology)
Paleontology
Pathology
RANKL
Adverse effect
Bone remodeling
Family medicine
Fetus
Gastroenterology
Heart failure
Immunology
In vitro